02197

1.34010.67%
JG

Joshua G. Liang

CEO & Executive Director

Mr. Joshua G. Liang is Executive Director and Chief Executive Officer at Clover Biopharmaceuticals, Ltd. since December 25, 2020. Mr. Liang is primarily responsible for leading the management and operation of all functional departments and supervising product strategy of our Group. Mr. Liang joined our Group in April 2016 as the chief strategy officer of Sichuan Clover. In addition to the positions in our Company, Mr. Liang is serving the following positions in our Group: a director and the chief executive officer of Sichuan Clover since September 2017 and since June 2020, respectively; a director and the general manager of Zhejiang Clover since August 2016; the executive director and general manager of Beijing Clover since August 2020; the executive director and general manager of Shanghai Clover since February 2021; the chief executive officer of U.S. Clover since April 2020; the executive director and chief executive officer of Australia Clover since December 2020; and a director of HK Clover since December 2020. Prior to joining our Group, Mr. Liang served as an analyst at Centerview Partners from July 2014 to February 2016, where he was mainly responsible for assisting in analyzing industry dynamics, competitive positioning and business strategies. Mr. Liang obtained his bachelor’s degrees in both economics and biology from the University of Pennsylvania in May 2014 in the U.S.

Positions